Literature DB >> 21596220

Characteristics and outcomes of Fusobacterium nucleatum bacteremia--a 6-year experience at a tertiary care hospital in northern Taiwan.

Chien-Chang Yang1, Jung-Jr Ye, Po-Chang Hsu, Hong-Jyun Chang, Chun-Wen Cheng, Hsieh-Shong Leu, Ping-Cherng Chiang, Ming-Hsun Lee.   

Abstract

Fusobacterium nucleatum bacteremia is critical and not well defined. To identify the clinical characteristics and outcomes, we conducted a retrospective review of hospitalized patients from January 2004 to December 2009 at a tertiary center in northern Taiwan. Fifty-seven patients were enrolled. The mean age was 58.1 years, and the mean Pitt bacteremia score was 4.7. Males predominated (59.6%), and the overall 30-day mortality rate was up to 47.4%. Malignancy was the major comorbidity (26/57, 45.6%), especially oropharyngeal and gastrointestinal cancers (19/26, 73.1%). Pneumonia (17/57, 29.8%) was the most common presentation with high rates of respiratory failure (15/17, 88.2%) and mortality (11/17, 64.7%), followed by intra-abdominal infections (7/57, 12.3%). In multivariate analysis, higher Pitt bacteremia score, nosocomial infection, anemia, and intensive care unit stay were the independent factors for 30-day mortality. Nosocomial F. nucleatum bacteremia was a significant mortality predictor independent to other parameters of disease severities.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21596220     DOI: 10.1016/j.diagmicrobio.2010.12.017

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  13 in total

1.  Pyogenic liver abscess caused by Fusobacterium in a 21-year-old immunocompetent male.

Authors:  Zohair Ahmed; Saurabh K Bansal; Sonu Dhillon
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Fusobacterium nucleatum infections: clinical spectrum and bacteriological features of 78 cases.

Authors:  E Denes; O Barraud
Journal:  Infection       Date:  2016-01-18       Impact factor: 3.553

3.  Fusobacterium nucleatum infection mimicking metastatic cancer.

Authors:  Armin Rashidi; Sami G Tahhan; Mark W Cohee; Benjamin M Goodman
Journal:  Indian J Gastroenterol       Date:  2012-08-09

4.  Fusobacterium Nucleatum Empyema: An Atypical Presentation.

Authors:  Lucía Barrera-López; Cristina Macía-Rodríguez; Lucía Ferreiro-Fernández; José Antonio Díaz-Peromingo
Journal:  Eur J Case Rep Intern Med       Date:  2020-04-24

5.  Fusobacterium invasive infections in children: a retrospective study in two French tertiary care centres.

Authors:  M Bailhache; P Mariani-Kurkdjian; P Lehours; J Sarlangue; P Pillet; E Bingen; A Faye
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-03-08       Impact factor: 3.267

6.  Epidemiology and clinical outcomes of patients with Fusobacterium bacteraemia.

Authors:  E A Goldberg; T Venkat-Ramani; M Hewit; H F Bonilla
Journal:  Epidemiol Infect       Date:  2012-04-17       Impact factor: 4.434

7.  Comparison of 16S Ribosomal RNA Targeted Sequencing and Culture for Bacterial Identification in Normally Sterile Body Fluid Samples: Report of a 10-Year Clinical Laboratory Review.

Authors:  In Young Yoo; On Kyun Kang; Myoung Keun Lee; Yae Jean Kim; Sun Young Cho; Kyungmin Huh; Cheol In Kang; Doo Ryeon Chung; Kyong Ran Peck; Hee Jae Huh; Nam Yong Lee
Journal:  Ann Lab Med       Date:  2020-01       Impact factor: 3.464

8.  Fusobacterium nucleatum Pleural Empyema in a Patient with Progressive Rheumatoid Arthritis and Immunosuppression.

Authors:  Wesley Tang; Zi Yu Liu; Charles Abreu
Journal:  Case Rep Infect Dis       Date:  2021-07-10

9.  Incidence, risk factors, and outcomes of Fusobacterium species bacteremia.

Authors:  Kevin Afra; Kevin Laupland; Jenine Leal; Tracie Lloyd; Daniel Gregson
Journal:  BMC Infect Dis       Date:  2013-06-05       Impact factor: 3.090

10.  Clinical Features and Outcomes of Fusobacterium Species Infections in a Ten-Year Follow-up.

Authors:  Rafael Garcia-Carretero; Marta Lopez-Lomba; Blanca Carrasco-Fernandez; Maria Teresa Duran-Valle
Journal:  J Crit Care Med (Targu Mures)       Date:  2017-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.